Literature DB >> 31201956

Hyperlipidemia induces meibomian gland dysfunction.

Jinghua Bu1, Yang Wu1, Xiaoxin Cai1, Nan Jiang1, M Vimalin Jeyalatha1, Jingwen Yu1, Xin He1, Hui He1, Yuli Guo1, Mingjie Zhang1, Andrew J Quantock2, Zuguo Liu1, Wei Li3.   

Abstract

PURPOSE: To investigate the pathological changes of the meibomian gland (MG) and ocular surface in Apolipoprotein E knockout (ApoE-/-) mice and to investigate the association of meibomian gland dysfunction (MGD) with hyperlipidemia.
METHODS: Total plasma cholesterol was measured in different ages of ApoE-/- and wild type (WT) mice, whilst the ocular surfaces were observed by slit-lamp biomicroscopy. MG sections were subjected to H&E staining, Oil Red O staining, TUNEL assay and immunostaining. Quantitate RT-PCR and Western blot analyses were performed to detect the relative gene expression in MGs. The 5-month-old ApoE-/- mice were administered with rosiglitazone or GW9662 + rosiglitazone via oral gavage for 2 months to determine their effect on MG pathological change.
RESULTS: We found eyelid abnormality, MG dropout, abnormal MG acinar morphology, dilated MG duct and plugging of the MG orifice in ApoE-/- mice. MG acini in ApoE-/- mice showed exaggerated lipid accumulation. Abnormal keratinization increased in MG duct, accompanied with decreased proliferation and increased apoptosis in ApoE-/- mice. Inflammatory cells infiltrated into the surrounding microenvironment of MG acini, and the NF-κB signaling pathway was activated in MG acinar cells. Oxidative stress was evident in MG acinar cells of ApoE-/- mice. Further investigation showed downregulation of PPAR-γ in MG acinar cells of ApoE-/- mice. PPAR-γ agonist rosiglitazone treatment reduced the morbidity of eyelid, as well as corneal pathological changes and MG inflammation in ApoE-/- mice.
CONCLUSION: MGD and hyperlipidemia are closely associated in ApoE-/- mice, which represent a new model to study the pathophysiology of MGD related to dyslipidemia.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apolipoprotein E; Hyperlipidemia; Inflammation; Meibomian gland dysfunction; PPAR-γ

Year:  2019        PMID: 31201956     DOI: 10.1016/j.jtos.2019.06.002

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  12 in total

Review 1.  Androgen and meibomian gland dysfunction: from basic molecular biology to clinical applications.

Authors:  Li-Xiang Wang; Ying-Ping Deng
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

2.  Meibomian gland dysfunction in geriatric population: tehran geriatric eye study.

Authors:  Hassan Hashemi; Amir Asharlous; Mohamadreza Aghamirsalim; Abbasali Yekta; Rama Pourmatin; Masoome Sajjadi; Mojgan Pakbin; Mohammadreza Asadollahi; Mehdi Khabazkhoob
Journal:  Int Ophthalmol       Date:  2021-03-24       Impact factor: 2.031

3.  Indirect Application of Intense Pulsed Light Induces Therapeutic Effects on Experimental Murine Meibomian Gland Dysfunction.

Authors:  Luoying Xie; Wenjing Song; Wenhui Dong; Yingsi Li; Shudi Chen; Xiaona Sun; Meiting Huang; Yu Cheng; Yuan Gao; Songlin Yang; Xiaoming Yan
Journal:  Front Med (Lausanne)       Date:  2022-06-02

Review 4.  Meibomian Gland Dysfunction: What Have Animal Models Taught Us?

Authors:  Mingxia Sun; Isabel Y Moreno; Michelle Dang; Vivien J Coulson-Thomas
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

5.  Evaluation of Meibomian Gland Function after Therapy of Eyelid Tumors at Palpebral Margin with Super Pulse CO2 Laser.

Authors:  Songjiao Zhao; Jueni Duan; Jing Zhang; Lan Gong
Journal:  Dis Markers       Date:  2022-01-17       Impact factor: 3.434

6.  Hyperglycemia Induces Meibomian Gland Dysfunction.

Authors:  Yuli Guo; Houjian Zhang; Zhongyang Zhao; Xin Luo; Minjie Zhang; Jinghua Bu; Minghui Liang; Han Wu; Jingwen Yu; Hui He; Rongrong Zong; Yongxiong Chen; Zuguo Liu; Wei Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

7.  Lipidomics Profiles Revealed Alterations in Patients With Meibomian Gland Dysfunction After Exposure to Intense Pulsed Light.

Authors:  Hui Zhao; Shi-Nan Wu; Yi Shao; Dong Xiao; Li-Ying Tang; Zhe Cheng; Jie Peng
Journal:  Front Neurol       Date:  2022-02-15       Impact factor: 4.003

8.  Melatonin Attenuates LPS-Induced Proinflammatory Cytokine Response and Lipogenesis in Human Meibomian Gland Epithelial Cells via MAPK/NF-κB Pathway.

Authors:  Ren Liu; Jing Li; Yue Xu; Ziyan Chen; Huijing Ye; Jinhui Tang; Lai Wei; Lingyi Liang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-05-02       Impact factor: 4.925

9.  Association of Meibomian Gland Dysfunction with Oral Statin Use.

Authors:  Sun-Kyoung Park; Ji-Hye Lee; Ho-Sik Hwang; Hyun-Seung Kim; Kyung-Do Han; Kyung-Sun Na
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

10.  Characterization of Meibomian Gland Atrophy and the Potential Risk Factors for Middle Aged to Elderly Patients With Cataracts.

Authors:  Xiaolei Lin; Yue Wu; Yiqin Chen; Yuyu Zhao; Linfeng Xiang; Qi Dai; Yana Fu; Yinying Zhao; Yun-E Zhao
Journal:  Transl Vis Sci Technol       Date:  2020-06-30       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.